Member Info for crumbs

Https://twitter.com/MiningInMalawi/status/1659096308307709953/photo/1

Look at the past news of the theSCIB1 poster presented by Poulam Patel at the 2015 ASCO...... obviously, we hope Modi 1 gets much more interest than SCIB 1 did despite it being a perfectly good vaccine (now improved)

https://www.scancell.co.uk/asco-update-on-phase-12-clinical-trial-of-scib1-in-stage-iiiiv-melanoma

Yeah, Prof Ottensmeir will be going there with the most up-to-date data ... expect an RNS containing it

Https://www.youtube.com/watch?v=F27h-zolni0

A decent little Webinar and positive from Will to a question on MDA progress... obviously the parties are getting close to agreements on those sticking points

'VANCOUVER, BC / ACCESSWIRE / May 17, 2023 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) ("CoTec" or the "Company") is pleased to announce that it has notified Mkango Resources Ltd ("Mkango") and Maginito Ltd ("Maginito") of its intention to increase its equity position in Maginito from 10 percent to approximately 20.6 percent.

CoTec intends to convert its GBP2 million convertible loan note in Mkango into Maginito stock on completion of Maginito's recently announced acquisition of the 58 percent equity interest in HyProMag it does not already own.'

Those pics I think are of Trish receiving Keytruda infusions as Modi 1 is a much simpler process using a microneedle device .... another plus point of the vaccine

Mcpherson needs to be the next one to do a Thompson and go... the truth is revisions have been pushed through in delivery offices where the majority of mail now cannot be delivered to USO required standards .... that's on the likes of Mcpherson

The US is certainly building a presence in Malawi, this from today

https://twitter.com/Times360Malawi/status/1656617741497905156

Https://news.sky.com/story/royal-mail-chief-simon-thompson-in-talks-to-put-stamp-on-exit-plan-12876356

It's not news journos we need to bother about letting it wither on a vine it is Pharma CEOs!!! :)

I'd like to think after years of keeping interested parties informed as to modi 1 progress it is now beyond the formal email exchange stages and now ticking enough boxes for there to be real discussions of we are interested and where do we go from here.....

Certainly again that Scancell seems to have booked zero events either product showrooming ones or can shaking fund raising ones and only AACR ASCO ... makes me think possibly that is indeed where we are now at as in previous years scancell traveled everywhere to try to gain interest ...

Well, we do get an extra none market day to sing about it :)

As for scancell news as far as ModiFY is concerned I would think there will certainly in this case unlike AACR be a trial update pre-ASCO for the good prof to go there with all the latest patient data

As for anything else, well... take your pick from the pipeline and surprises lol but ModiFY is now mainstream media (yeah local at the moment but it is out there to share))

My position on who is as I've said that it is the Clatterbridge and prof Ottensmeier ....As for any Scancell involvement at most I would suggest prof Ottensmeier told them about it coming and asked if it was ok to use the name of the trial and their company name to which Scancell will have said Sure go for it which is better for us than just 'new experimental treatment' and that being it.... But IMHO they have not suggested the article in the first place it is not as if this is the first Echo article about trial successes The prof and Clatterbridge have been involved in ... There are others...

The added angle for us here is ASCO is coming up and we know who is going to the US to present the trial paper none other than prof Ottensmeier ....This suggests he is liking what he is seeing with the Modify trial so far and that is good enough for me at this point....

Also I and I know I can include many here in that to make a we... We have taken a very big risk here in backing moditope into a trial with no partner... So words like this are fantastic and moving to read and I honestly cannot believe any other investor could feel differently to me on that one.

"To have this kind of effect over such a short space of time gives you a lot of hope - and hope that this treatment can be there and be even better for people in the future.

"Although I was a nurse, I was community-based so did not get involved with clinical trials. So the whole process has been new to me. But everything was explained so thoroughly and I understood what was going to happen to me.

"I feel absolutely brilliant – it is the easiest treatment I've ever had. There have been no real side-effects. And this is one of the remarkable things, that it has been a total breeze compared to other cancer treatments, such as chemotherapy and radiotherapy.

"When I was a paediatric nurse, I saw the effects that chemotherapy had on children. To think that this new treatment could become standard is really amazing.

“I don't think I'd been here now if I was not on this clinical trial - I've felt like all the planets aligned for me. The Clatterbridge team have been so supportive. They never make you feel like you have been left alone."

To think this new treatment could become standard..... now that is why I took the risk.

We once had a young male patient on the SCIB1 trial appear on a BBC program and a lady getting an ICHOR jab on some program neither were anything to do with scancell they came from the trial clinics... trial clinics promote what they do... that is how they get patients and funding... I'm afraid there is nothing I can do to alter your moral compass from being all over the place... again it is a good news story as simple as that... don't worry about it I'm not I'm very happy that a product I have invested in is making her life better simple as that and hopefully many others too....

Of course it's the clinic they want to encourage more trial participants...it's a good news story and anyone that takes it otherwise has ...issues

It'll be nothing to do with Scancell PR it's the Liverpool clinic putting it out...where it goes from there dunno but great to hear from Trish in the media and such trial bolstering words

C11 some now have trading decisions to make ....it's hard lol

It's ok to call Trish Trish now .... great find WTP the ASCO build up is on....As for personalised well moditope does target individuals own unique epitopes it does it in a super clever but simple way so it can be classed as a personalised therapy but one that may work in all of us and that's the part Mr market may get one day....but probably only after Mr pharma gets it first 😄

When I say a probable investor I don't mean CW I mean someone that posts there in the interests of pushing modi 1 trial info and fishing ..... sad really I think it is a line not to be crossed but there it is